Skip to main content

Table 2 Intraoperative and postoperative outcomes

From: Long-term outcomes of robot-assisted versus minimally invasive esophagectomy in patients with thoracic esophageal cancer: a propensity score-matched study

 

Before matching

 

After matching

 
 

MIE

RAMIE

P value

MIE

RAMIE

P value

No. of patients (%)

43

43

 

26

26

 

Thoracic operative time (min) mean

229(128–460)

250(162–339)

0.019§

240.5(148–460)

241.5(193–339)

0.110#

Blood loss (ml) mean

65(0–446)

26(0–600)

< 0.001§

62.5(0–446)

31.5(0–355)

0.012#

3-FLND

13(30.2)

4(9.3)

0.028‡

7(26.9)

4(15.4)

0.508¶

Dissected thoracic lymph nodes

25(5–60)

24(8–58)

0.638§

28(5–60)

25(10–57)

0.404#

Postoperative hospital stay

27(18–102)

13(8–40)

< 0.001§

28(18–102)

14(8–35)

< 0.001#

Pathological T factor

  

0.002‡

  

0.200

 Tis, 1a / 1b / 2 / 3

1(2.3)/23(53.5)/3(7.0)/16(37.2)

5(11.6)/31(72.1)/5(11.6)/2(4.7)

 

1(3.8)/17(65.4)/1(3.8)/7(26.9)

3(11.5)/18(69.2)/3(11.5)/2(7.7)

 

Pathological N factor

  

0.375‡

  

0.023

 0 / 1 / 2

27(62.8)/15(34.9)/1(2.3)

26(60.5)/13(30.2)/4(9.3)

 

18(69.2)/8(30.8)/0(0)

19(73.1)/5(19.2)/2(7.7)

 

Pathological TNM stage

  

0.465‡

  

0.306

 0 / I / II / III

10(23.3)/9(20.9)/14(32.6)/10(23.3)

15(34.9)/11(25.6)/11(25.6)/6(14.0)

 

8(30.8)/6(23.1)/8(30.8)/4(15.4)

11(42.3)/7(26.9)/5(19.2)/3(11.5)

 

Postoperative complication (CD ≧ II)

20(46.5)

10(23.3)

0.04

13(50.0)

5(19.2)

0.021¶

 Pneumonia

5(11.6)

3(7.0)

0.713‡

2(7.7)

1(3.8)

1.000¶

 Anastomotic leakage

  

0.110‡

  

0.125¶

 Type I / Type II

0(0)/6(14.0)

0(0)/1(2.3)

 

0(0)/4(15.4)

0(0)/0(0)

 

RLN paralysis

  

0.112

  

0.070¶

   I

12(27.9)

6(14.0)

 

10(38.5)

4(15.4)

 

Chylothorax

  

1.000‡

  

-

 Type I

0(0)

1(2.3)

 

0(0)

0(0)

 

Recurrence

11(25.6)

10(23.3)

0.802

6(23.1)

6(23.1)

1.000¶

  1. MIE: minimally invasive esophagectomy, RAMIE: robot-assisted minimally invasive esophagectomy, FLND: Field lymphatic node dissection, CD: Clavien–Dindo classification, RLN: Recurrent laryngeal nerve
  2. ‡Pearson’s χ2 test or Fisher’s exact test, except §Wilcoxon rank-sum test
  3. ¶McNemar’s test or McNemar’s exact test, except #Wilcoxon signed-rank test